Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesMolecular ImagingPET/CT detects bone involvement in patients with lymphomaResearch suggests that F-18 FDG-PET/CT could replace invasive bone marrow biopsy.Practice ManagementInsurer benchmark used for NSA disputes lower than in-network rateMRIIs 7-tesla MRI poised for routine clinical integration?MRIOnline safety screening for MRI exams reduces prep time, cancellationsDigital X-RayDark-field radiography improves detection of pneumothorax
